Table 5.

Clinical data for the most frequent diagnosesab

Biopsy DiagnosisnMaleHTNcHematuriaNephrotic RangeSerum Albumin (g/dl)Serum Creatinine (mg/dl)Urine Protein(g/24 h)
Pauci-immune GN3926%(10/39)50%(9/18)97%(32/33)24%(5/21)2.6±0.6(22/39)4.4±2.9(36/39)2.948±3.104(20/39)
FSGS secondary to HTN/aging1656%(9/16)67%(4/6)30%(3/10)33%(5/15)3.3±0.6(9/16)2.7±1.1(16/16)3.368±1.984(15/16)
Hypertensive nephrosclerosis1553%(8/15)50%(4/8)0%(0/8)17%(2/12)3.9±0.5(9/15)2.3±0.73(15/15)1.673±2.044(12/15)
Membranous nephropathy1533%(5/15)57%(4/7)54%(7/13)85%(11/13)2.2±0.5(14/15)1.5±0.8(14/15)8.207±4.389(13/15)
IgA nephropathy1587%(13/15)33%(2/6)80%(12/15)31%(4/13)3±0.5(11/15)3.2±1.3(13/15)3.477±3.104(11/15)
Amyloidosis1369%(9/13)0%(0/6)30%(3/10)75%(9/12)2.3±1.1(12/13)2.3±2.9(12/13)7.010±5.308(10/13)
Myeloma cast nephropathy933%(3/9)0%(0/2)40%(2/5)60%(3/5)3.5±1.1(7/9)5.2±2.7(8/9)3.580±1.362(5/9)
MCD967%(6/9)40%(2/5)38%(3/8)89%(8/9)2.3±0.4(8/9)2.4±1.6(7/9)8.651±5.391(9/9)
  • a Biopsies with multiple diagnoses are excluded.

  • b Serum albumin, serum creatinine level, and 24-h urine protein level are expressed as the mean ± SD, whereas the fraction in parentheses represents the number of patients for whom data was available. For categorical variables, the numerator represents the number of patients with a particular finding and the denominator represents the total number of patients with available data. Hematuria includes gross and/or microscopic hematuria.

  • c HTN, presence of HTN at presentation; FSGS, focal segmental glomerulosclerosis; HTN, hypertension; MCD, minimal change disease.